相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Matthew Gagne et al.
CELL (2022)
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
Alexandra Tauzin et al.
CELL HOST & MICROBE (2022)
Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2
Hongjie Xia et al.
CELL HOST & MICROBE (2022)
Antibody glycosylation in COVID-19
Tamas Pongracz et al.
GLYCOCONJUGATE JOURNAL (2022)
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Paulina Kaplonek et al.
IMMUNITY (2022)
Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals
Brian Grunau et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Germinal centre-driven maturation of B cell response to mRNA vaccination
Wooseob Kim et al.
NATURE (2022)
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
Victoria Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Nick Andrews et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Peter B. Gilbert et al.
SCIENCE (2022)
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Saborni Chakraborty et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis
David A. Spencer et al.
NATURE COMMUNICATIONS (2022)
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison Greaney et al.
PLOS PATHOGENS (2022)
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
Wael Bahnan et al.
FRONTIERS IN IMMUNOLOGY (2022)
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer et al.
LANCET MICROBE (2022)
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira et al.
NATURE (2022)
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C. Bartsch et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Sialylation as an Important Regulator of Antibody Function
Ravi Vattepu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
Tamas Pongracz et al.
EBIOMEDICINE (2022)
A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
Nasruddeen Al-Awwal et al.
PATHOGENS (2022)
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
Jonathan D. Herman et al.
CELL REPORTS MEDICINE (2022)
Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19
Sokratis A. Apostolidis et al.
FRONTIERS IN IMMUNOLOGY (2022)
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw et al.
NATURE REVIEWS IMMUNOLOGY (2022)
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Luca Perico et al.
NATURE REVIEWS NEPHROLOGY (2021)
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19
Henry Ng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
Alexandra Schafer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Jordan R. Barrett et al.
NATURE MEDICINE (2021)
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan et al.
SCIENCE (2021)
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Mads Delbo Larsen et al.
SCIENCE (2021)
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Wilfredo F. Garcia-Beltran et al.
CELL (2021)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler et al.
CELL (2021)
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
Gabriele Cerutti et al.
CELL HOST & MICROBE (2021)
Platelet FcγRIIA in immunity and thrombosis: Adaptive immunothrombosis
Pravin Patel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Humoral signatures of protective and pathological SARS-CoV-2 infection in children
Yannic C. Bartsch et al.
NATURE MEDICINE (2021)
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel et al.
SCIENCE (2021)
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Jonathan D. Herman et al.
NATURE COMMUNICATIONS (2021)
Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
Savannah E. Butler et al.
FRONTIERS IN IMMUNOLOGY (2021)
Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
Inbal Farkash et al.
CELL REPORTS (2021)
Stabilized coronavirus spike stem elicits a broadly protective antibody
Ching-Lin Hsieh et al.
CELL REPORTS (2021)
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain
Adam K. Wheatley et al.
CELL REPORTS (2021)
Covalent Stabilization of Antibody Recruitment Enhances Immune Recognition of Cancer Targets
Eden Kapcan et al.
BIOCHEMISTRY (2021)
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum et al.
CELL (2021)
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Toni M. Delorey et al.
NATURE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
Gabriele Anichini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages
Willianne Hoepel et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions
Opeyemi S. Adeniji et al.
MBIO (2021)
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan et al.
MBIO (2021)
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Ge Song et al.
NATURE COMMUNICATIONS (2021)
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
Sisi Kang et al.
NATURE COMMUNICATIONS (2021)
Evaluation of COVID-19 vaccination strategies with a delayed second dose
Seyed M. Moghadas et al.
PLOS BIOLOGY (2021)
Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
Gyorgy Sinkovits et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
Lina Ma et al.
SCIENCE IMMUNOLOGY (2021)
Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
Alexander P. Bye et al.
BLOOD (2021)
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
Fatima Amanat et al.
CELL (2021)
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin et al.
CELL HOST & MICROBE (2021)
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah et al.
IMMUNITY (2021)
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Frauke Muecksch et al.
IMMUNITY (2021)
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation
Thijs L. J. van Osch et al.
JOURNAL OF IMMUNOLOGY (2021)
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Rachel Yamin et al.
NATURE (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia
Angela Huynh et al.
NATURE (2021)
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner et al.
NATURE (2021)
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Galit Alter et al.
NATURE (2021)
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Begin et al.
NATURE MEDICINE (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Conrad E. Z. Chan et al.
PLOS ONE (2021)
IgA potentiates NETosis in response to viral infection
Hannah D. Stacey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants
Amarendra Pegu et al.
SCIENCE (2021)
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
Kizzmekia S. Corbett et al.
SCIENCE (2021)
Broad betacoronavirus neutralization by a stem helix-specific human antibody
Dora Pinto et al.
SCIENCE (2021)
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou et al.
FRONTIERS IN MICROBIOLOGY (2021)
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Youssif M. Ali et al.
FRONTIERS IN IMMUNOLOGY (2021)
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Tom G. Caniels et al.
SCIENCE ADVANCES (2021)
Neutrophils and Influenza: A Thin Line between Helpful and Harmful
Sneha T. George et al.
VACCINES (2021)
Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
Ger T. Rijkers et al.
VACCINES (2021)
Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
Matthew J. Gorman et al.
CELL REPORTS MEDICINE (2021)
A new flow cytometry assay to measure antibody- dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells
Guillaume Beaudoin-Bussieres et al.
STAR PROTOCOLS (2021)
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients
Yuanling Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Sai Priya Anand et al.
CELL REPORTS MEDICINE (2021)
Broad auto-reactive IgM responses are common in critically ill patients, including those with COVID-19
Andrew Kam Ho Wong et al.
CELL REPORTS MEDICINE (2021)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
Andrea R. Shiakolas et al.
CELL REPORTS MEDICINE (2021)
Proinflammatory IgG Fc structures in patients with severe COVID-19
Saborni Chakraborty et al.
NATURE IMMUNOLOGY (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases
Lucija Klaric et al.
SCIENCE ADVANCES (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
Kenrie P. Y. Hui et al.
LANCET RESPIRATORY MEDICINE (2020)
Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
Sin Fun Sia et al.
NATURE (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Antibody responses to SARS-CoV-2 in patients with COVID-19
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
Elizabeth A. Middleton et al.
BLOOD (2020)
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Caroline Atyeo et al.
IMMUNITY (2020)
The complement system in COVID-19: friend and foe?
Anuja Java et al.
JCI INSIGHT (2020)
Thrombosis inCOVID-19
Thomas C. Hanff et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Julien Carvelli et al.
NATURE (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Ann M. Arvin et al.
NATURE (2020)
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Vijendra Ramlall et al.
NATURE MEDICINE (2020)
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
Mangaiarkarasi Asokan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
Panagiotis Skendros et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Kinetics of viral load and antibody response in relation to COVID-19 severity
Yanqun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Animal models for COVID-19
Cesar Munoz-Fontela et al.
NATURE (2020)
The Power of Antibody-Based Surveillance
Galit Alter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Tomer Zohar et al.
CELL (2020)
The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19)
Angelica Arcanjo et al.
SCIENTIFIC REPORTS (2020)
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Xiangyu Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Isolation, Sequence, Infectivity and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2
Arinjay Banerjee et al.
EMERGING INFECTIOUS DISEASES (2020)
Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza
Yang Mei et al.
ECLINICALMEDICINE (2020)
A novel method for determining antibody-dependent cellular phagocytosis
Lynn Kamen et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity
Nirmin Alsahafi et al.
CELL HOST & MICROBE (2019)
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation
Stephanie Fischinger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley et al.
FRONTIERS IN IMMUNOLOGY (2019)
Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets
Matthew H. Bakalar et al.
CELL (2018)
High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection
Liuluan Zhu et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Impact of HIV-1 Envelope Conformation on ADCC Responses
Jonathan Richard et al.
TRENDS IN MICROBIOLOGY (2018)
Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
Yuting Jiang et al.
EMERGING MICROBES & INFECTIONS (2018)
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Disease
Gillian Dekkers et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Immunoglobulin G glycosylation in aging and diseases
Ivan Gudelja et al.
CELLULAR IMMUNOLOGY (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
Beyond binding: antibody effector functions in infectious diseases
Lenette L. Lu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
Eric P. Brown et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms
Kirstie L. S. Cleary et al.
JOURNAL OF IMMUNOLOGY (2017)
Affinity of human IgG subclasses to mouse Fc gamma receptors
Gillian Dekkers et al.
MABS (2017)
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Marie Toussaint et al.
NATURE MEDICINE (2017)
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
Wenqian He et al.
NATURE COMMUNICATIONS (2017)
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
Gillian Dekkers et al.
FRONTIERS IN IMMUNOLOGY (2017)
Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection
Yu-Jin Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Defining B cell immunodominance to viruses
Davide Angeletti et al.
NATURE IMMUNOLOGY (2017)
Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease
Bart Cortjens et al.
JOURNAL OF PATHOLOGY (2016)
Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells
Wing Y. Lam et al.
IMMUNITY (2016)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman et al.
PLOS PATHOGENS (2016)
Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen
Yariv Mazor et al.
PLOS ONE (2016)
Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy
Taia T. Wang et al.
CELL (2015)
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung et al.
CELL (2015)
Mouse and human FcR effector functions
Pierre Bruhns et al.
IMMUNOLOGICAL REVIEWS (2015)
Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza
Veronika I. Zarnitsyna et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus
Ying Wu et al.
NATURE COMMUNICATIONS (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Peering into the Crystal Ball: Influenza Pandemics and Vaccine Efficacy
Matthew S. Miller et al.
CELL (2014)
Actin Cytoskeleton Reorganization by Syk Regulates Fcγ Receptor Responsiveness by Increasing Its Lateral Mobility and Clustering
Valentin Jaumouille et al.
DEVELOPMENTAL CELL (2014)
Clonal selection in the germinal centre by regulated proliferation and hypermutation
Alexander D. Gitlin et al.
NATURE (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus
Fumihiko Yasui et al.
VIROLOGY (2014)
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Maja Pucic Bakovic et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b
Margaret E. Ackerman et al.
JOURNAL OF VIROLOGY (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Properties of mouse and human IgG receptors and their contribution to disease models
Pierre Bruhns
BLOOD (2012)
Poorly Neutralizing Cross-Reactive Antibodies against the Fusion Loop of West Nile Virus Envelope Protein Protect In Vivo via Fcγ Receptor and Complement-Dependent Effector Mechanisms
Matthew R. Vogt et al.
JOURNAL OF VIROLOGY (2011)
A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fcγ Receptors To Define the Role of Effector Functions in Protection against HIV
Brian Moldt et al.
JOURNAL OF VIROLOGY (2011)
The Human Antibody Response to Dengue Virus Infection
Wahala M. P. B. Wahala et al.
VIRUSES-BASEL (2011)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Monomeric and polymeric IgA show a similar association with the myeloid FcαRI/CD89
Beatrijs D. Oortwijn et al.
MOLECULAR IMMUNOLOGY (2007)
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Mac-1 (CD11b/CD18) as accessory molecule, for FcαR (CD89) binding of IgA
AB van Spriel et al.
JOURNAL OF IMMUNOLOGY (2002)
Recognition of IgG by Fcγ receptor -: The role of Fc glycosylation and the binding of peptide inhibitors
S Radaev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)